Amplify Weight Loss Drug & Treatment ETF
THNR
4 hedge funds and large institutions have $1.17M invested in Amplify Weight Loss Drug & Treatment ETF in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
27% more capital invested
Capital invested by funds: $919K → $1.17M (+$251K)
4.8% more ownership
Funds ownership: 22% → 26.8% (+4.8%)
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$431K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$8.76K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$6.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
GTS Securities
Miami,
Florida
|
-$240K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$4.75K |
THNR Hedge Fund Activity: Q2 2026 in Review
4 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Amplify Weight Loss Drug & Treatment ETF (THNR) for Q2 2026, worth a combined $1.17M — up 27% from $919K a quarter earlier.
Fund positioning in THNR was balanced in Q2 2026: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $431K. The largest seller was GTS Securities, exiting entirely with an estimated $240K sold.
- 4 institutional investors held Amplify Weight Loss Drug & Treatment ETF (THNR) as of Q2 2026, unchanged from Q1 2026.
- Funds reported $1.17M of Amplify Weight Loss Drug & Treatment ETF stock for Q2 2026, up 27% quarter-over-quarter.
- 2 funds opened new Amplify Weight Loss Drug & Treatment ETF positions in Q2 2026 and 2 closed out, a net change of 0 holders.
- The largest Amplify Weight Loss Drug & Treatment ETF buyer in Q2 2026 was Jane Street, an estimated $431K added.
- The largest Amplify Weight Loss Drug & Treatment ETF seller in Q2 2026 was GTS Securities, an estimated $240K sold.
Based on aggregated 13F filings for Q2 2026.